Sonicates of Mycobacterium intracellulare grown in synthetic medium were separated into ammonium sulfate (50%) precipitable and nonprecipitable fractions. Gel filtration of the precipitable fraction through columns of Sephacryl S-300 resulted in four fractions labeled A, B, C and D in order of elution. Fractions C and D were further fractionated into 12 and 13 subfractions, respectively. The subfractions were examined for reactivity by rocket immunoelectrophoresis (R-IE) procedures and by skin tests in homologously and heterologously immunized guinea pigs (M. kansasii, M. fortuitum, M. marinum, M. scrofulaceum and M. bovis). Extensive sharing of antigenic determinants was observed for all of the reactive subfractions by R-IE. None of the subfractions showed significant skin test specificity. Possible reasons for the nonspecificity are discussed.

Download full-text PDF

Source

Publication Analysis

Top Keywords

mycobacterium intracellulare
8
serologic cellular
4
cellular cross-reactivity
4
fractions
4
cross-reactivity fractions
4
fractions mycobacterium
4
intracellulare battey
4
battey sonicates
4
sonicates mycobacterium
4
intracellulare grown
4

Similar Publications

The incidence of infections caused by the complex (MAC) has risen significantly, posing diagnostic and therapeutic challenges. This study analyzed 134 clinical isolates of the complex from southern Spain, performing in vitro antimicrobial susceptibility testing using a commercial microdilution technique to generate additional data, refine treatment strategies, and improve patient outcomes. Phenotypic susceptibility testing revealed clarithromycin and amikacin as the most effective antibiotics, with susceptibility rates exceeding 90%, while linezolid and moxifloxacin exhibited limited activity, with resistance rates of 49.

View Article and Find Full Text PDF

Pulmonary cavitary disease due to Mycobacterium intracellulare cured in a healthy young adult leaving only calcifications.

Int J Infect Dis

January 2025

Division of Internal Medicine, Japan Agricultural Cooperatives Kochi Hospital, 526-1 Myoken-aza-Nakano, Nankoku, Kochi 783-8509, Japan; Department of Community Medicine for Respirology, Graduate School of Biomedical Sciences, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan. Electronic address:

View Article and Find Full Text PDF

The Mycobacterium avium complex (MAC) is a group of closely related nontuberculous mycobacteria that can cause various diseases in humans. In this study, genome sequencing, comprehensive genomic analysis, and antimicrobial susceptibility testing of 66 MAC clinical isolates from King Chulalongkorn Memorial Hospital, Bangkok, Thailand were carried out. Whole-genome average nucleotide identity (ANI) revealed the MAC species distribution, comprising 54 (81.

View Article and Find Full Text PDF

Introduction The prevalence of nontuberculous mycobacteria (NTM) is higher in patients with structural lung disease and in immunocompromised patients. Lung involvement is the most common. The complex corresponds to the most identified agent.

View Article and Find Full Text PDF

Mycobacterium avium complex bacteria cause chronic pulmonary disease (MAC-PD) in susceptible patients [1]. The recommended treatment regimen (rifampicin, ethambutol and azithromycin) achieves 65% cure rates but with considerable toxicity and drug-drug interactions [2,3]. Minocycline proved active in monotherapy experiments using the hollow-fibre model [4].

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!